Centre May Extend Customs Duty Relief on Pharma Raw Materials Amid West Asia Conflict
New Delhi: The Centre is considering extending customs duty exemptions on key petrochemical inputs used by the pharmaceutical industry beyond June 30, as authorities assess the impact of the ongoing conflict in West Asia on manufacturing costs and supply chains.
The duty relief, introduced earlier this year as a temporary measure, covers a range of petrochemical products that serve as critical raw materials for several industries, including pharmaceuticals. The move was aimed at ensuring uninterrupted supplies and shielding manufacturers from rising input costs amid geopolitical disruptions.
Government officials indicated that the situation in West Asia continues to be closely monitored and that a decision on extending the exemptions will be taken after evaluating developments in the region and their implications for domestic industries. Concerns remain that prolonged instability could further disrupt global supply chains and increase the cost of essential raw materials.
The pharmaceutical sector is among the major beneficiaries of the duty waiver, as several drug manufacturers depend on petrochemical derivatives for the production of medicines and formulations. Industry stakeholders have maintained that the temporary exemption has helped contain cost pressures and support stable production during a period of uncertainty.
Officials noted that any extension of the relief measures would be intended to safeguard domestic manufacturing, maintain the availability of critical inputs and prevent a sharp increase in production expenses. The government is also examining the broader impact of geopolitical tensions on trade flows and industrial operations.
According to a recent media report in The Hindu, the possible extension is being considered in view of continuing concerns over supply disruptions and cost escalation linked to the West Asia conflict. The report noted that the government remains engaged with industry stakeholders while reviewing the need for continued support measures.
The final decision on extending the customs duty exemptions is expected to be taken before the current relief period ends on June 30. Industry participants are closely watching the government's next move, as the continuation of the waiver could provide further protection against volatility in raw material costs and supply availability.
